FDA seeks new warnings on arthritis drugs
September 2, 2021Medical Communications
The FDA has requested that Pfizer, Eli Lilly, and AbbVie include additional warnings on their arthritis drugs about the risks …
Moderna submits data to FDA for COVID-19 vaccine booster
September 2, 2021Moderna has initiated its submission to the FDA for the evaluation of a booster dose of the Moderna COVID-19 vaccine. …
NICE and Cochrane to collaborate on living recommendations
September 1, 2021Medical Communications, Research and Development
NICE has announced a collaboration with Cochrane, in which Cochrane will help deliver ‘living’ recommendations across the NICE guideline portfolio. …
Viper venom found to inhibit COVID virus from multiplying
September 1, 2021Medical Communications, Research and Development
Brazilian researchers have found that a molecule in the venom of a jararacussu pit viper can prevent coronavirus reproduction. The …
AI test screens for COVID-19 26% faster than lateral flow tests
September 1, 2021Research and Development
A University of Oxford-led study has shown that COVID-19 screening results were available 45 minutes after patients arrived in the …
Fourth contaminated Moderna vial found in Japan
September 1, 2021Medical Communications, Research and Development
A fourth contamination case in less than a week in Japan has been reported involving Moderna’s COVID-19 vaccine, which threatens …
NICE approves life-saving cholesterol drug for NHS
September 1, 2021Research and Development
NICE has approved the ground-breaking cholesterol-lowering drug inclisiran, made by Novartis, for use on the NHS. This is an option …
Empagliflozin demonstrates significant improvement in heart failure outcomes
August 31, 2021Manufacturing and Production
Empagliflozin (Jardiance) showed a significant 21% relative risk reduction for the composite primary endpoint of cardiovascular death or hospitalisation for …
Dupilumab significantly reduces atopic dermatitis in children
August 31, 2021Manufacturing and Production
A pivotal Phase III trial evaluating dupilumab for the treatment of children aged six months to five years with moderate-to-severe …
Bone Therapeutics knee osteoarthritis Phase III study misses primary endpoints
August 31, 2021Manufacturing and Production
Bone Therapeutics, the cell therapy company addressing unmet medical needs in orthopaedics and other diseases, announced that the Phase III …
AlzeCure’s Alzheimer’s project receives approval to start phase I study
August 31, 2021Manufacturing and Production
AlzeCure Pharma AB, a pharmaceutical company that develops a broad portfolio of candidate drugs for diseases affecting the central nervous …
New Zealand woman dies after receiving Pfizer COVID vaccine
August 31, 2021Manufacturing and Production
New Zealand has reported what they believe to be the first death associated with the Pfizer vaccine. An independent vaccine …
Blood-clot risk “substantially higher” from COVID than from jabs
August 27, 2021Medical Communications
The risks of developing a blood clot are “substantially higher” after catching coronavirus than following a COVID vaccine, research shows. …
UCB’s bimekizumab granted marketing authorisation by MHRA for plaque psoriasis
August 27, 2021Medical Communications
UCB’s bimekizumab has been granted marketing authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of …
NICE rejects combination treatment for multiple myeloma
August 27, 2021Medical Communications
NICE does not recommend daratumumab (Darzalex, Janssen Cilag), plus bortezomib, thalidomide and dexamethasone, as a treatment option for untreated multiple …
CARMAT’s artificial heart commercially implanted successfully for third time
August 27, 2021Medical Communications
CARMAT’s artificial heart, Aeson, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, has been …
New PPE mask range can begin to kill SARS-CoV-2 on contact
August 27, 2021Medical Communications
A new PPE mask range has been launched that can begin to kill SARS-CoV-2 and other viruses and pathogens on …
Genetic cause of endometriosis identified alongside potential drug target
August 26, 2021New research, published in Science Translational Medicine, has identified the genetic cause of endometriosis which in turn has identified a …
Malaria sickness could be cut by 70%, study finds
August 26, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have found a new approach to protecting young African …
Positive Phase III trial results for AstraZeneca in flushing copper from tissues
August 26, 2021AstraZeneca’s ALXN1840 demonstrated approximately three times greater copper mobilisation from tissues than standard-of-care treatments.Results from the FoCus Phase III trial …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
